Med Surg Solutions is proud to introduce the GORE TAG Thoracic Branch Endoprosthesis—the first endovascular graft to be granted both FDA, SFDA and MDR CE mark approval, setting a new benchmark in aortic arch disease treatment.

Traditionally, treating aortic arch disease has been complex and high-risk. This single-device system simplifies Zone 2 revascularization, eliminating the need for surgical LSA debranching, significantly reducing procedural risks, and improving patient safety and efficiency.

Backed by 25+ years of thoracic aortic innovation, this device is designed for long-term durability, combining the conformability of the GORE TAG Conformable Device with the ability to endovascularly perfuse the left subclavian artery (LSA).

With Med Surg Solutions, the future of aortic repair is here—safer, more effective, and redefining patient outcomes.